OR7A8P

Across TCGA pan-cancer cohorts, OR7A8P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR7A8P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR7A8P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7A8P is over-expressed in tumor.

THCA, LUAD, and KIRC are the cancer types where OR7A8P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7A8P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.046	<.001	3	view →
LUAD	All	All	+0.013	.026	2	view →
KIRC	Male	IV	+0.094	.022	1	view →
ESCA	Female	All	+0.056	<.001	1	view →
HNSC	All	II,III,IV	+0.014	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR7A8P–THCA

Open the THCA breakdown →